Arginine Vasopressin V1a Receptor Antagonist Impairs Maternal Memory in Rats

Physiology and Behavior - United States
doi 10.1016/j.physbeh.2008.05.016
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Vasopressin Analogues and V1a Receptor Agonists in Septic Shock

Inflammation Research
ImmunologyPharmacology
2011English

Acute Hemodynamic Effects of Conivaptan, a Dual V1A and V2 Vasopressin Receptor Antagonist, in Patients With Advanced Heart Failure

Circulation
Cardiovascular MedicinePhysiologyCardiology
2001English

Low Body Weight at Weaning in V1a Vasopressin Receptor Knockout Mice

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

Azetidinones as Vasopressin V1a Antagonists

Bioorganic and Medicinal Chemistry
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2007English

Pharmacological Profile of VP-343, a Novel Selective Vasopressin V2 Receptor Antagonist, in Rats.

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2000English

NMDA Receptor Antagonist Ketamine Impairs Feature Integration in Visual Perception

PLoS ONE
Multidisciplinary
2013English

Arginine Vasopressin Alters Both Spontaneous and Phase-Locked Synaptic Inputs to Airway Vagal Preganglionic Neuron via Activation of V1a Receptor: Insights Into Stress-Related Airway Vagal Excitation

Frontiers in Cellular Neuroscience
Molecular NeuroscienceCellular
2017English

Transmission Disequilibrium Testing of Arginine Vasopressin Receptor 1A (AVPR1A) Polymorphisms in Autism

Molecular Psychiatry
PsychiatryMolecular NeuroscienceMental HealthMolecular BiologyCellular
2002English

Arginine Vasopressin and Copeptin in Perinatology

Frontiers in Pediatrics
Child HealthPediatricsPerinatology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy